Show Navigation
search results
Cart Lightbox Client Area
Prev 63 of 299 Next

20200526_zia_z03_100.jpg

Add to Lightbox Download

May 26, 2020, Fredrick, Maryland, USA: Colorized scanning electron micrograph of a dead cell heavily infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample. REMDESIVIR, a drug treatment appears to shorten recovery time for people with coronavirus according to new research. UK Health Secretary Hancock said it was probably the biggest step forward in the treatment of coronavirus since the crisis began. Remdesivir is an anti-viral medicine that has been used against Ebola. Researchers there is enough evidence to approve its use in selected Covid-19 hospital patients.The US and Japan have made urgent arrangements to provide early access to the medicine before they have a marketing agreement. The drug is currently undergoing clinical trials around the world. Early data suggests it can cut recovery time by about four days, but there is no evidence yet that it will save more lives. Remdesivir is superior to the standard of care for the treatment of COVID-19, according to the research published in The New England Journal of Medicine. The preliminary analysis is based on data from a treatment trial.
Made by the American government's National Institute of Allergy and Infectious Diseases (NIAID) at NIAID IRF (National Institute for Allergy and Infectious Diseases Integrated Research Facility) Fort Detrick. The SARS-CoV-2 which causes COVID-19 disease first discovered December 2019 in Wuhan, China. (Credit Image: © NIAID via ZUMA Wire)

Filename
20200526_zia_z03_100.jpg
Copyright
Represented by ZUMA Press, Inc. RealTime Images RealTime Images
Image Size
3543x3053 / 2.7MB
www.zumapress.com
Contained in galleries
Pic Search - 27 Aug 2020
May 26, 2020, Fredrick, Maryland, USA: Colorized scanning electron micrograph of a dead cell heavily infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample. REMDESIVIR, a drug treatment appears to shorten recovery time for people with coronavirus according to new research. UK Health Secretary Hancock said it was probably the biggest step forward in the treatment of coronavirus since the crisis began. Remdesivir is an anti-viral medicine that has been used against Ebola. Researchers there is enough evidence to approve its use in selected Covid-19 hospital patients.The US and Japan have made urgent arrangements to provide early access to the medicine before they have a marketing agreement. The drug is currently undergoing clinical trials around the world. Early data suggests it can cut recovery time by about four days, but there is no evidence yet that it will save more lives. Remdesivir is superior to the standard of care for the treatment of COVID-19, according to the research published in The New England Journal of Medicine. The preliminary analysis is based on data from a treatment trial.<br /> Made by the American government's National Institute of Allergy and Infectious Diseases (NIAID) at NIAID IRF (National Institute for Allergy and Infectious Diseases Integrated Research Facility) Fort Detrick. The SARS-CoV-2 which causes COVID-19 disease first discovered December 2019 in Wuhan, China. (Credit Image: © NIAID via ZUMA Wire)